64 related articles for article (PubMed ID: 37473463)
1. Therapy-related myeloid neoplasm in early breast cancer patients treated with adjuvant chemotherapy.
Lee JW; Oh H; You JY; Lee ES; Lee JH; Song SE; Lee NK; Jung SP; An JS; Cho KR; Kim CY; Park KH
Eur J Cancer; 2023 Sep; 191():112952. PubMed ID: 37473463
[TBL] [Abstract][Full Text] [Related]
2. Maximizing Breast Cancer Therapy with Awareness of Potential Treatment-Related Blood Disorders.
Kaplan HG; Calip GS; Malmgren JA
Oncologist; 2020 May; 25(5):391-397. PubMed ID: 32073195
[TBL] [Abstract][Full Text] [Related]
3. [Clinical characteristics and prognosis of patients with therapy-related myelodysplastic syndrome and acute myeloid leukemia arising from malignant tumors].
Xu XS; Ding H; Zhang X; Liao Y; Li H; Liu QY; Liu JZ; Zhang L; Huang J; Gong YP; Ma HB; Xiang B; Dai Y; Hou L; Shuai X; Niu T; Wu Y
Zhonghua Xue Ye Xue Za Zhi; 2023 Sep; 44(9):742-748. PubMed ID: 38049318
[No Abstract] [Full Text] [Related]
4. Cumulative exposure to melphalan chemotherapy and subsequent risk of developing acute myeloid leukemia and myelodysplastic syndromes in patients with multiple myeloma.
Jonsdottir G; Björkholm M; Turesson I; Hultcrantz M; Diamond B; Porwit A; Landgren O; Kristinsson SY
Eur J Haematol; 2021 Aug; 107(2):275-282. PubMed ID: 33966293
[TBL] [Abstract][Full Text] [Related]
5. Association between meat, fish, and fatty acid intake and incidence of acute myeloid leukemia and myelodysplastic syndrome: the Japan Public Health Center-based Prospective Study.
Shimomura Y; Sobue T; Zha L; Kitamura T; Iwasaki M; Inoue M; Yamaji T; Tsugane S; Sawada N
Environ Health Prev Med; 2023; 28():19. PubMed ID: 36878605
[TBL] [Abstract][Full Text] [Related]
6. Incidence and predictors of anthracycline-related left ventricular dysfunction in acute myeloid leukemia.
Stahl M; Giblin G; Liu Y; Winer ES; Garcia JS; Chen E; Wadleigh M; Ling K; Lindsley RC; Shimony S; Copson K; Charles A; DeAngelo DJ; Stone RM; Nohria A; Luskin MR
Leuk Res; 2023 Sep; 132():107351. PubMed ID: 37451200
[TBL] [Abstract][Full Text] [Related]
7. Risk of cancer in relatives of patients with myelodysplastic neoplasia and acute leukemias.
Nitschke NJ; Rostgaard K; Andersen MK; Hjalgrim H; Grønbæk K
Cancer Epidemiol; 2024 Feb; 88():102523. PubMed ID: 38198910
[TBL] [Abstract][Full Text] [Related]
8. Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patients.
Qiao X; van der Zanden SY; Li X; Tan M; Zhang Y; Song JY; van Gelder MA; Hamoen FL; Janssen L; Zuur CL; Pang B; van Tellingen O; Li J; Neefjes J
Mol Cancer; 2024 Jun; 23(1):120. PubMed ID: 38831402
[TBL] [Abstract][Full Text] [Related]
9. DNA-PKcs-mediated transcriptional regulation of TOP2B drives chemoresistance in acute myeloid leukemia.
Mishra SV; Banerjee A; Sarkar D; Thangarathnam V; Bagal B; Hasan SK; Dutt S
J Cell Sci; 2024 Feb; 137(3):. PubMed ID: 38240344
[TBL] [Abstract][Full Text] [Related]
10. Second malignancies after multiple myeloma: from 1960s to 2010s.
Thomas A; Mailankody S; Korde N; Kristinsson SY; Turesson I; Landgren O
Blood; 2012 Mar; 119(12):2731-7. PubMed ID: 22310913
[TBL] [Abstract][Full Text] [Related]
11. [Environmental and occupational risk factors for myelodysplastic syndrome].
Garnier R
Bull Cancer; 2023 Nov; 110(11):1116-1128. PubMed ID: 37419729
[TBL] [Abstract][Full Text] [Related]
12. Subsequent female breast cancer risk associated with anthracycline chemotherapy for childhood cancer.
Wang Y; Ronckers CM; van Leeuwen FE; Moskowitz CS; Leisenring W; Armstrong GT; de Vathaire F; Hudson MM; Kuehni CE; Arnold MA; Demoor-Goldschmidt C; Green DM; Henderson TO; Howell RM; Ehrhardt MJ; Neglia JP; Oeffinger KC; van der Pal HJH; Robison LL; Schaapveld M; Turcotte LM; Waespe N; Kremer LCM; Teepen JC;
Nat Med; 2023 Sep; 29(9):2268-2277. PubMed ID: 37696934
[TBL] [Abstract][Full Text] [Related]
13. Long-term cardiovascular disease risk after anthracycline and trastuzumab treatments in U.S. breast cancer survivors.
Vo JB; Ramin C; Veiga LHS; Brandt C; Curtis RE; Bodelon C; Barac A; Roger VL; Feigelson HS; Buist DSM; Bowles EJA; Gierach GL; Berrington de González A
J Natl Cancer Inst; 2024 May; ():. PubMed ID: 38718210
[TBL] [Abstract][Full Text] [Related]
14. High Expression of ENO1 and Low Levels of Circulating Anti-ENO1 Autoantibodies in Patients with Myelodysplastic Neoplasms and Acute Myeloid Leukaemia.
Lincz LF; Theron DZ; Barry DL; Scorgie FE; Sillar J; Sefhore O; Enjeti AK; Skelding KA
Cancers (Basel); 2024 Feb; 16(5):. PubMed ID: 38473245
[TBL] [Abstract][Full Text] [Related]
15. Myeloid neoplasms post cytotoxic therapy: epidemiology, pathogenesis outcomes, prognostic factors, and treatment options.
Ma J; Wang Y
Ann Med; 2024 Dec; 56(1):2329132. PubMed ID: 38608646
[TBL] [Abstract][Full Text] [Related]
16. Single arm phase II trial assessing the safety, compliance with and activity of Bezafibrate and medroxyProgesterone acetate (BaP) therapy against myeloid and lymphoid cancers.
Murray J; Pratt G; Jacob A; Clark F; Blundred R; Fox S; Bishop R; Wheatley K; Khanim F; Bunce C; Drayson M
Contemp Clin Trials Commun; 2019 Jun; 14():100361. PubMed ID: 31011660
[TBL] [Abstract][Full Text] [Related]
17. Cognitive Function in Adults With Acute Myeloid Leukemia Treated With Chemotherapy: A Systematic Review.
Chan YN; Betancur S; Conklin JL; Hirschey R; Piepmeier A; Foster M; Anderson RA; Bender CM; Bryant AL
Cancer Nurs; 2024 Mar-Apr 01; 47(2):121-131. PubMed ID: 36066343
[TBL] [Abstract][Full Text] [Related]
18. Double trouble: IRAK1/4 inhibitors in AML/MDS.
Uckelmann HJ; Klusmann JH
Blood; 2023 Sep; 142(11):945-946. PubMed ID: 37707874
[No Abstract] [Full Text] [Related]
19. Acute myeloid leukemia post‑cytotoxic therapy following chemotherapy for thymoma: A case report.
Manabe M; Tani Y; Inano N; Hagiwara Y; Sogabe N; Nanno S; Koh KR
Med Int (Lond); 2024; 4(1):9. PubMed ID: 38283133
[TBL] [Abstract][Full Text] [Related]
20. Clinical and Genomic Risk in Adjuvant Therapy for Breast Cancer.
Giorgi Rossi P; Lebeau A; Schünemann HJ;
N Engl J Med; 2019 Sep; 381(13):1289-1290. PubMed ID: 31553845
[No Abstract] [Full Text] [Related]
[Next] [New Search]
